Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Genome-wide screen for modulation of hepatic apolipoprotein A-I (ApoA-I) secretion.

Miles RR, Perry W, Haas JV, Mosior MK, N'Cho M, Wang JW, Yu P, Calley J, Yue Y, Carter Q, Han B, Foxworthy P, Kowala MC, Ryan TP, Solenberg PJ, Michael LF.

J Biol Chem. 2013 Mar 1;288(9):6386-96. doi: 10.1074/jbc.M112.410092. Epub 2013 Jan 15.

PMID:
23322769
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDL.

Marchesi M, Parolini C, Caligari S, Gilio D, Manzini S, Busnelli M, Cinquanta P, Camera M, Brambilla M, Sirtori CR, Chiesa G.

Br J Pharmacol. 2011 Nov;164(5):1460-8. doi: 10.1111/j.1476-5381.2011.01429.x.

PMID:
21486287
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Dietary fat elevates hepatic apoA-I production by increasing the fraction of apolipoprotein A-I mRNA in the translating pool.

Azrolan N, Odaka H, Breslow JL, Fisher EA.

J Biol Chem. 1995 Aug 25;270(34):19833-8.

PMID:
7649994
[PubMed - indexed for MEDLINE]
Free Article
4.

ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes.

Sahoo D, Trischuk TC, Chan T, Drover VA, Ho S, Chimini G, Agellon LB, Agnihotri R, Francis GA, Lehner R.

J Lipid Res. 2004 Jun;45(6):1122-31. Epub 2004 Mar 1.

PMID:
14993246
[PubMed - indexed for MEDLINE]
Free Article
5.

Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.

Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J, Yang F, Durante W, Chan L, Schafer AI, Pownall HJ, Yang X, Wang H.

Circ Res. 2006 Sep 15;99(6):598-606. Epub 2006 Aug 24.

PMID:
16931800
[PubMed - indexed for MEDLINE]
Free Article
6.

Reduced biliary sterol output with no change in total faecal excretion in mice expressing a human apolipoprotein A-I variant.

Parolini C, Caligari S, Gilio D, Manzini S, Busnelli M, Montagnani M, Locatelli M, Diani E, Giavarini F, Caruso D, Roda E, Roda A, Sirtori CR, Chiesa G.

Liver Int. 2012 Oct;32(9):1363-71. doi: 10.1111/j.1478-3231.2012.02855.x. Epub 2012 Jul 29.

PMID:
22845860
[PubMed - indexed for MEDLINE]
7.
8.

Safe and sustained overexpression of functional apolipoprotein A-I/high-density lipoprotein in apolipoprotein A-I-null mice by muscular adeno-associated viral serotype 8 vector gene transfer.

Cimmino G, Chen W, Speidl WS, Giannarelli C, Ibanez B, Fuster V, Hajjar R, Walsh CE, Badimon JJ.

J Cardiovasc Pharmacol. 2009 Nov;54(5):405-11. doi: 10.1097/FJC.0b013e3181bad264.

PMID:
19701094
[PubMed - indexed for MEDLINE]
9.

ApoA-I lipidation in primary mouse hepatocytes. Separate controls for phospholipid and cholesterol transfers.

Zheng H, Kiss RS, Franklin V, Wang MD, Haidar B, Marcel YL.

J Biol Chem. 2005 Jun 3;280(22):21612-21. Epub 2005 Mar 29.

PMID:
15797865
[PubMed - indexed for MEDLINE]
Free Article
10.

Effects of nevirapine and efavirenz on HDL cholesterol levels and reverse cholesterol transport in mice.

Tohyama J, Billheimer JT, Fuki IV, Rothblat GH, Rader DJ, Millar JS.

Atherosclerosis. 2009 Jun;204(2):418-23. doi: 10.1016/j.atherosclerosis.2008.09.016. Epub 2008 Sep 27.

PMID:
18990393
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Hepatic high-density lipoprotein secretion regulates the mobilization of cell-surface hepatic lipase.

Chatterjee C, Young EK, Pussegoda KA, Twomey EE, Pandey NR, Sparks DL.

Biochemistry. 2009 Jun 30;48(25):5994-6001. doi: 10.1021/bi802009e.

PMID:
19425605
[PubMed - indexed for MEDLINE]
12.

Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor.

Masson D, Koseki M, Ishibashi M, Larson CJ, Miller SG, King BD, Tall AR.

Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2054-60. doi: 10.1161/ATVBAHA.109.191320. Epub 2009 Oct 8.

PMID:
19815817
[PubMed - indexed for MEDLINE]
Free PMC Article
13.
14.

Identification of genes affecting apolipoprotein B secretion following siRNA-mediated gene knockdown in primary human hepatocytes.

Shen X, Wang W, Wang L, Houde C, Wu W, Tudor M, Thompson JR, Sisk CM, Hubbard B, Li J.

Atherosclerosis. 2012 May;222(1):154-7. doi: 10.1016/j.atherosclerosis.2012.02.012. Epub 2012 Feb 16.

PMID:
22398276
[PubMed - indexed for MEDLINE]
15.

Effect of experimental nephrosis on hepatic lipoprotein secretion and urinary lipoprotein excretion in rats expressing the human apolipoprotein A-I gene.

Marsh JB, Diffenderfer MR, Fisher EA, Sowden M, Dong M, Paterniti JR, Burkey BF.

J Lipid Res. 1996 May;37(5):1113-24.

PMID:
8725162
[PubMed - indexed for MEDLINE]
Free Article
16.

Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice.

Yue P, Chen Z, Nassir F, Bernal-Mizrachi C, Finck B, Azhar S, Abumrad NA.

PLoS One. 2010 Mar 26;5(3):e9906. doi: 10.1371/journal.pone.0009906.

PMID:
20360851
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice.

Srivastava RA.

Mol Cell Biochem. 2000 Jun;209(1-2):125-9.

PMID:
10942210
[PubMed - indexed for MEDLINE]
18.

Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.

Zhong S, Goldberg IJ, Bruce C, Rubin E, Breslow JL, Tall A.

J Clin Invest. 1994 Dec;94(6):2457-67.

PMID:
7989603
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Proteolytic degradation and impaired secretion of an apolipoprotein A-I mutant associated with dominantly inherited hypoalphalipoproteinemia.

McManus DC, Scott BR, Franklin V, Sparks DL, Marcel YL.

J Biol Chem. 2001 Jun 15;276(24):21292-302. Epub 2001 Apr 5.

PMID:
11292828
[PubMed - indexed for MEDLINE]
Free Article
20.

The thienotriazolodiazepine Ro 11-1464 increases plasma apoA-I and promotes reverse cholesterol transport in human apoA-I transgenic mice.

Zanotti I, Maugeais C, Pedrelli M, Gomaraschi M, Salgam P, Calabresi L, Bernini F, Kempen H.

Br J Pharmacol. 2011 Nov;164(6):1642-51. doi: 10.1111/j.1476-5381.2011.01376.x.

PMID:
21449977
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk